↓ Skip to main content

Advances in Cancer Biomarkers

Overview of attention for book
Cover of 'Advances in Cancer Biomarkers'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Cancer Biomarkers: A Status Quo
  3. Altmetric Badge
    Chapter 2 Cancer Biomarkers Discovery and Validation: State of the Art, Problems and Future Perspectives
  4. Altmetric Badge
    Chapter 3 Use of Biomarkers in Screening for Cancer.
  5. Altmetric Badge
    Chapter 4 The Role of Metabolomics in the Study of Cancer Biomarkers and in the Development of Diagnostic Tools
  6. Altmetric Badge
    Chapter 5 The Role of Epigenomics in the Study of Cancer Biomarkers and in the Development of Diagnostic Tools.
  7. Altmetric Badge
    Chapter 6 Efficient, Adaptive Clinical Validation of Predictive Biomarkers in Cancer Therapeutic Development
  8. Altmetric Badge
    Chapter 7 Prostate Specific Antigen as a Tumor Marker in Prostate Cancer: Biochemical and Clinical Aspects
  9. Altmetric Badge
    Chapter 8 The Actual Role of LDH as Tumor Marker, Biochemical and Clinical Aspects
  10. Altmetric Badge
    Chapter 9 Neuron-Specific Enolase as a Biomarker: Biochemical and Clinical Aspects
  11. Altmetric Badge
    Chapter 10 Components of the Plasminogen-Plasmin System as Biologic Markers for Cancer
  12. Altmetric Badge
    Chapter 11 The Role of Human Chorionic Gonadotropin as Tumor Marker: Biochemical and Clinical Aspects.
  13. Altmetric Badge
    Chapter 12 Advances in Cancer Biomarkers
  14. Altmetric Badge
    Chapter 13 Mucins and Cytokeratins as Serum Tumor Markers in Breast Cancer
  15. Altmetric Badge
    Chapter 14 The Role of CA 125 as Tumor Marker: Biochemical and Clinical Aspects
  16. Altmetric Badge
    Chapter 15 CA 19-9: Biochemical and Clinical Aspects.
  17. Altmetric Badge
    Chapter 16 Non Coding RNA Molecules as Potential Biomarkers in Breast Cancer
  18. Altmetric Badge
    Chapter 17 Urinary Prostate Cancer Antigen 3 as a Tumour Marker: Biochemical and Clinical Aspects
  19. Altmetric Badge
    Chapter 18 Biomarker in Cisplatin-Based Chemotherapy for Urinary Bladder Cancer
  20. Altmetric Badge
    Chapter 19 A Critical Approach to Clinical Biochemistry of Chromogranin A.
  21. Altmetric Badge
    Chapter 20 The Actual Role of Receptors as Cancer Markers, Biochemical and Clinical Aspects: Receptors in Breast Cancer
  22. Altmetric Badge
    Chapter 21 The Role of CTCs as Tumor Biomarkers
Attention for Chapter 21: The Role of CTCs as Tumor Biomarkers
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (54th percentile)
  • Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

policy
1 policy source

Citations

dimensions_citation
31 Dimensions

Readers on

mendeley
129 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
The Role of CTCs as Tumor Biomarkers
Chapter number 21
Book title
Advances in Cancer Biomarkers
Published in
Advances in experimental medicine and biology, January 2015
DOI 10.1007/978-94-017-7215-0_21
Pubmed ID
Book ISBNs
978-9-40-177214-3, 978-9-40-177215-0
Authors

Evi S. Lianidou, Athina Markou, Areti Strati

Abstract

Detection of Circulating Tumor Cells (CTCs) in peripheral blood can serve as a "liquid biopsy" approach and as a source of valuable tumor markers. CTCs are rare, and thus their detection, enumeration and molecular characterization are very challenging. CTCs have the unique characteristic to be non-invasively isolated from blood and used to follow patients over time, since these cells can provide significant information for better understanding tumour biology and tumour cell dissemination. CTCs molecular characterization offers the unique potential to understand better the biology of metastasis and resistance to established therapies and their analysis presents nowadays a promising field for both advanced and early stage patients. In this chapter we focus on the latest findings concerning the clinical relevance of CTC detection and enumeration, and discuss their potential as tumor biomarkers in various types of solid cancers. We also highlight the importance of performing comparison studies between these different methodologies and external quality control systems for establishing CTCs as tumor biomarkers in the routine clinical setting.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 129 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Iran, Islamic Republic of 1 <1%
Portugal 1 <1%
Ireland 1 <1%
Unknown 126 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 20 16%
Student > Bachelor 16 12%
Student > Ph. D. Student 14 11%
Student > Master 14 11%
Student > Doctoral Student 12 9%
Other 18 14%
Unknown 35 27%
Readers by discipline Count As %
Medicine and Dentistry 42 33%
Biochemistry, Genetics and Molecular Biology 15 12%
Agricultural and Biological Sciences 12 9%
Pharmacology, Toxicology and Pharmaceutical Science 4 3%
Immunology and Microbiology 3 2%
Other 16 12%
Unknown 37 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 May 2022.
All research outputs
#7,536,586
of 22,994,508 outputs
Outputs from Advances in experimental medicine and biology
#1,230
of 4,960 outputs
Outputs of similar age
#106,433
of 354,157 outputs
Outputs of similar age from Advances in experimental medicine and biology
#60
of 272 outputs
Altmetric has tracked 22,994,508 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,960 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.1. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 354,157 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.
We're also able to compare this research output to 272 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.